Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
了解更多
Luminex Licensed Technologies Partner Spotlight: Radix BioSolutions
Custom assay development
At Radix, scientists design and manufacture Luminex assays so their customers can focus on what they’re really interested in: the results. The company is one of our Licensed Technologies Partners, a group that includes a wide range of markets, organization types, and locations. All of the Licensed Technologies Partners conduct work that is powered by Luminex’s versatile xMAP® Technology, which has supported the launch of thousands of multiplexed immunoassays as the basis for commercially available kits and testing services.
Continue Reading >
xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.
Watch more videos >
August 6
Luminex Corporation Reports Second Quarter 2018 Financial Results
July 13
Luminex Corporation Second Quarter Earnings Release Scheduled for August 6, 2018
June 13
Luminex Initiates Clinical Trials for VERIGENE® II Gastrointestinal Assay
May 18
Luminex Corporation to Present at Upcoming Healthcare Investor Conferences
May 18
Luminex Corporation Declares Second Quarter Cash Dividend
xMAP® Connect Boston
September 18
Boston, MA
IDWeek
October 3-7
San Francisco, CA
AMP Annual Meeting
November 1-3
San Antonio, TX
xMAP® Connect Amsterdam
November 6-7
Amsterdam, Netherlands
